Contact us for free information or to start a free case review.
The U.S. Food and Drug Administration (FDA) notified healthcare professionals about new data that links Multaq® (dronedarone) to severe liver injuries. According to a letter sent on Jan. 14, 2011, the FDA received two reports of acute liver failure in Multaq® users.
The two patients were diagnosed with acute liver failure within six months of taking Multaq®, says the FDA. Both patients required liver transplants.
If you are taking Multaq® for the treatment of abnormal heart rhythms, you should be aware of the symptoms of acute liver failure, including:
If you experience any combination of these symptoms, you should consult your doctor immediately. Acute liver failure develops rapidly and can have fatal consequences.
Patients that develop liver failure are at risk of ling-term complications such as pressure in the brain, bleeding disorders, infection and kidney failure. It is important to seek medication attention as soon as possible to prevent further damage to your health.
The FDA warning involving Multaq® (dronedarone) says information about the risk of severe liver injury will be added to the warning and precautions and adverse reactions sections of the drug's label. The stronger warning label intends to inform patients about the potential side effects and to educate them about the associated symptoms.
The FDA also advises patients to discuss their concerns about potential Multaq® liver damage with their doctors and to not stop taking the medication unless advised to do so by a healthcare provider.
The FDA has asked all patients to report any Multaq® side effects to the FDA MedWatch program. This helps the agency keep track of the injuries caused by medications.
If you or a loved one has been diagnosed with acute liver failure and have a history of taking Multaq®, we may be able to help you get compensation for your injuries. Contact a Multaq® liver injury lawyer for help today.
The FDA notified healthcare professionals about new findings that link Multaq® to severe liver injuries, Jan. 14, 2011. The agency said there were two report...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.